Azithromycin therapy during respiratory syncytial virus bronchiolitis: Upper airway microbiome alterations and subsequent recurrent wheeze

Documenti analoghi

• Does Azithromycin Modify Viral Load During Severe RSV Bronchiolitis?
  di: Beigelman, Avraham, et al.
  Pubblicazione: (2015)
• Randomized trial to evaluate azithromycin’s effects on serum and upper airway IL-8 levels, and recurrent wheezing in infants with RSV bronchiolitis
  di: Beigelman, Avraham, et al.
  Pubblicazione: (2014)
• Vitamin D Levels Are Unrelated to the Severity of Respiratory Syncytial Virus Bronchiolitis Among Hospitalized Infants
  di: Beigelman, Avraham, et al.
  Pubblicazione: (2015)
• Impaired tumor necrosis factor‐α secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze
  di: Kitcharoensakkul, Maleewan, et al.
  Pubblicazione: (2020)
• The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population
  di: Srinivasan, Mythili, et al.
  Pubblicazione: (2021)